SCHEMBL13034032

SCHEMBL13034032

CC(C)(C)C(CCC(N)=O)C(C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
ALOX15 P16050 1/20 0.50
BLM P54132 1/20 0.50
PMP22 Q01453 1/20 0.50
DPP4 P27487 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
GABRP O00591 2/20 0.31
GABRD O14764 2/20 0.31
GABRA1 P14867 2/20 0.31
GABRB1 P18505 2/20 0.31
GABRG2 P18507 2/20 0.31
GABRB3 P28472 2/20 0.31
GABRA5 P31644 2/20 0.31
GABRA3 P34903 2/20 0.31
GABRA2 P47869 2/20 0.31
GABRB2 P47870 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12234122 0.78 BLM (0.54) KMT2AALOX15BLMPMP22DPP4
SCHEMBL22392171 0.78 ALOX15 (0.44) KMT2AALOX15BLMPMP22DPP4
SCHEMBL11930053 0.77 CYP1A2 (0.48) KMT2ABLMGABRPGABRDGABRA1
SCHEMBL13073781 0.75 KMT2A (0.40) KMT2AALOX15BLMPMP22DPP4
SCHEMBL12435671 0.75 ALOX15 (0.40) KMT2AALOX15BLMPMP22DPP4
SCHEMBL28967231 0.75 KMT2A (0.50) KMT2AALOX15BLMPMP22DPP4
SCHEMBL10034531 0.74 ECE1 (0.35) ALOX15BLMPMP22CA1CA2
SCHEMBL15793097 0.72
SCHEMBL2035631 0.72 KMT2A (0.46) KMT2AALOX15BLMPMP22DPP4
SCHEMBL12846937 0.72 KMT2A (0.46) KMT2AALOX15BLMPMP22DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105971571-B Method and composition for oil well and/or gas well 弗洛泰克化学有限责任公司 2019-10-15 CN disclosed
CN-106837217-B For oil well and/or the composition and method comprising terpenol of gas well 弗洛泰克化学有限责任公司 2019-07-02 CN disclosed
CN-105419750-B Method and composition for oil well and/or gas well 弗洛泰克化学有限责任公司 2019-03-22 CN disclosed
US-8633160-B2 Small molecule inhibitors of PDZ interactions NONO INC. (CA) 2014-01-21 US disclosed
US-20100298360-A1 SMALL MOLECULE INHIBITORS OF PDZ INTERACTIONS BELMARES MICHAEL P 2010-11-25 US disclosed
US-20090062213-A1 Small Molecule Inhibitors of PDZ Interactions ARBOR VITA CORPORATION (US) 2009-03-05 US disclosed
US-20080227684-A1 Small Molecule Inhibitors of PDZ Interactions NONO INC. (CA) 2008-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062213-A1 Small Molecule Inhibitors of PDZ Interactions PDLIM5, DAB2IP, PSD KMT2A 4312/4885ALOX15 4652/4885BLM 4309/4885
US-20080227684-A1 Small Molecule Inhibitors of PDZ Interactions PDLIM5, DAB2IP, PSD KMT2A 4312/4885ALOX15 4652/4885BLM 4309/4885
US-20100298360-A1 SMALL MOLECULE INHIBITORS OF PDZ INTERACTIONS PDLIM5, DAB2IP, PSD KMT2A 4312/4885ALOX15 4652/4885BLM 4309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.